C07D 277/52
To sulfur atoms
Official title: to sulfur atoms, e.g. sulfonamides
C07D277/52 (To sulfur atoms) appears on 123 US grants and 141 published applications in this corpus.
Search patents in C07D- Granted patents
- 123
- Published applications
- 141
- Assignees
- 108
- Inventors
- 502
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 2 |
| 2003 | 2 | 6 |
| 2004 | 1 | 10 |
| 2005 | 3 | 5 |
| 2006 | 9 | 6 |
| 2007 | 1 | 5 |
| 2008 | 3 | 4 |
| 2009 | 7 | 3 |
| 2010 | 4 | 6 |
| 2011 | 5 | 7 |
| 2012 | 9 | 4 |
| 2013 | 5 | 6 |
| 2014 | 4 | 4 |
| 2015 | 3 | 6 |
| 2016 | 3 | 8 |
| 2017 | 4 | 6 |
| 2018 | 2 | 8 |
| 2019 | 13 | 8 |
| 2020 | 6 | 10 |
| 2021 | 2 | 4 |
| 2022 | 6 | 4 |
| 2023 | 2 | 10 |
| 2024 | 1 | 6 |
| 2025 | 7 | 1 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- WDR5-MYC inhibitors10 Feb 2026US 12,545,649 B2Vanderbilt University
- Aminothiazole compounds as inhibitors of CTPS123 Dec 2025US 12,503,466 B2Step Pharma S.A.S.
- Sulphonyl urea derivatives as NLRP3 inflammasome modulators4 Nov 2025US 12,459,925 B2NodThera Limited
- CTPS1 inhibitors and uses thereof17 Jun 2025US 12,331,046 B2Nimbus Clotho, Inc.
- Compound as ctps1 inhibitor6 Aug 2026US 2026/0226026 A1Hangzhou Innogate Pharma Co., Ltd.
- N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels background6 Aug 2026US 2026/0226040 A1Merck Sharp & Dohme Corp.
- Compounds21 Aug 2025US 2025/0263407 A1Step Pharma S.A.A.
- Remodilins to prevent or treat cancer metastasis, glaucoma, and hypoxia19 Dec 2024US 2024/0415851 A1Beth Israel Deaconess Medical Center, Inc.
- Sulphonyl urea derivatives as nlrp3 inflammasome modulators7 Nov 2024US 2024/0368129 A1NodThera Limited
Most cited
By later US patents
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Aryl carbonyl derivatives as therapeutic agents123US 7,541,373 B2Novo Nordisk A/S · 2009
- Aryl aniline β2 adrenergic receptor agonists62US 6,670,376 B1Theravance, Inc. · 2003
- Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof56US 5,856,347 AHisamitsu Pharmaceutical Co., Inc. · 1999
- Aniline derivatives or salts thereof and cytokine production inhibitors containing the same46US 7,132,546 B2Ishihara Sangyo Kaisha, Ltd. · 2006